(Q44609550)

English

Immediate and Long-term Hemodynamic and Clinical Effects of Sildenafil in Patients With Pulmonary Arterial Hypertension Receiving Vasodilator Therapy

scientific article published on October 1, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Immediate and Long-term Hemodynamic and Clinical Effects of Sildenafil in Patients With Pulmonary Arterial Hypertension Receiving Vasodilator Therapy (English)

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

1 reference

based on heuristic

inferred from title

arterial hypertension

1 reference

based on heuristic

inferred from title

author name string

Sundeep Bhatia

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Robert P. Frantz

2

0000-0003-4128-3978

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531479

18 March 2024

Cathy J. Severson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531479

18 March 2024

Louise A. Durst

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531479

18 March 2024

Michael D. McGoon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531479

18 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0025619611628425?httpAccept=text/xml

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

https://api.elsevier.com/content/article/PII:S0025619611628425?httpAccept=text/plain

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

78

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1207-1213

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

2

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

3

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension

4

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

5

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

6

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

7

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Bosentan therapy for pulmonary arterial hypertension

8

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.

9

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine

10

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation.

11

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

12

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Nitric oxide and nitrovasodilators: similarities, differences and potential interactions

13

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

One-year continuous inhaled nitric oxide for primary pulmonary hypertension

14

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis

15

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

16

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension

17

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

New treatments for pulmonary arterial hypertension

18

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors

19

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

20

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Sildenafil in primary pulmonary hypertension

22

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

23

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Doppler echocardiographic index for assessment of global right ventricular function

25

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension

26

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Effects of sildenafil citrate on human hemodynamics.

27

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

28

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.

29

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

30

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Sildenafil for primary and secondary pulmonary hypertension

31

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Hemodynamic effects of sildenafil in men with severe coronary artery disease

32

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Sildenafil inhibits hypoxia-induced pulmonary hypertension

33

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee

34

1 reference

10.4065/78.10.1207

https://api.crossref.org/works/10.4065/78.10.1207

18 March 2024

Identifiers

10.4065/78.10.1207

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44609550&oldid=2105301163"